1. Home
  2. News
  3. Health News
  4. High Blood Pressure

High Blood Pressure

One short breathing exercise may help lower blood pressure, study finds

Experts say the technique could be an easy way for consumers to boost their heart health

A new study conducted by researchers from the University of Colorado at Boulder explored a new technique that may help consumers lower their blood pressure. 

According to their findings, a five-minute breathing exercise known as High-Resistance Inspiratory Muscle Strength Training (IMST), which requires consumers to breathe through a device that provides resistance, can lower blood pressure and benefit heart health.

“There are a lot of lifestyle strategies that we know ca...

Not sure how to choose?

Get expert buying tips about High Blood Pressure delivered to your inbox.

    By entering your email, you agree to sign up for consumer news, tips and giveaways from ConsumerAffairs. Unsubscribe at any time.

    Thank you, you have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.

    Recent Articles

    Sort by:

    Drinking alcohol increases risk of high blood pressure for those with type 2 diabetes, study finds

    Researchers say limiting alcohol consumption could lead to better health outcomes

    Recent studies have highlighted the negative health effects associated with alcohol consumption -- even in the most limited quantities. Now, researchers from the American Heart Association have identified those with type 2 diabetes as a particularly vulnerable group when it comes to drinking.  

    According to a new study, having more than one alcoholic drink per day could increase the risk of high blood pressure for those with type 2 diabetes. 

    “This is the first large study to specifically investigate the association of alcohol intake and hypertension among adults with type 2 diabetes,” said researcher Dr. Matthew J. Singleton. “Previous studies have suggested that heavy alcohol consumption was associated with high blood pressure, however, the association of moderate alcohol consumption with high blood pressure was unclear.” 

    The risks of moderate alcohol consumption

    The researchers had over 10,000 participants, all with type 2 diabetes, participate in the study. At the start of the study, the participants reported on how many alcoholic beverages they consumed per week, and the researchers monitored their blood pressure readings over the course of the study. 

    The biggest takeaway that the researchers gleaned was that excessive alcohol consumption greatly increases consumers’ risk of high blood pressure. However, they learned that even drinking moderately throughout the week can be problematic for those struggling with type 2 diabetes. Moderate drinking was defined as having eight to 14 drinks per week, and participants who fell into this group were nearly 80 percent more likely to develop high blood pressure. 

    These findings were consistent with those from another study, which found that moderate drinking for all consumers -- regardless of diabetes status -- can have a negative impact on blood pressure. 

    Limiting alcohol consumption

    The researchers learned that having a few drinks each week didn’t compromise participants’ blood pressure. Because of this, they recommend that consumers with type 2 diabetes take these findings into consideration when thinking about their own alcohol consumption. 

    “People with type 2 diabetes are at a higher cardiovascular risk, and our findings indicate that alcohol consumption is associated with hypertension, so limited drinking is recommended,” said Dr. Singleton. 

    Recent studies have highlighted the negative health effects associated with alcohol consumption -- even in the most limited quantities. Now, researchers fr...
    Read lessRead more

    High blood pressure is becoming more common for pregnant women

    Researchers have found an increase in the condition over the last 40 years

    High blood pressure is something all consumers need to keep an eye on, but a new study shows that pregnant women can be especially susceptible to the condition. 

    Researchers from the American Heart Association (AHA) found that cases of high blood pressure among pregnant women have been steadily increasing over the last 40 years. Those findings are dangerous because high blood pressure can be harmful to both mothers and their newborns. 

    “Women who already have high blood pressure and are planning to become pregnant should work closely with their healthcare provider to closely monitor and manage their blood pressure, especially during pregnancy, to reduce the serious health risks to both themselves and their unborn child,” said researcher Cande V. Ananth, PhD. 

    Monitoring potential health risks

    The researchers utilized data from the Centers for Disease Control and Prevention’s National Hospital Discharge Survey (NHDS) to determine blood pressure trends among pregnant women between 1970 and 2010. 

    In that time, over 151 million were hospitalized due to changes in blood pressure, all of whom were between the ages of 15 and 49. For the purpose of the study, the researchers were focused on women who either had high blood pressure before getting pregnant or were diagnosed with the condition up to 20 weeks into pregnancy. 

    The researchers discovered that while just over 0.10 percent of pregnant women had chronic high blood pressure at the start of the study in 1970, that figure jumped exponentially by 2010, with over 1.5 percent of pregnant women experiencing chronic high blood pressure by that date. 

    The study revealed that women who waited until later in life to become pregnant were at a greater risk of developing chronic high blood pressure during pregnancy, as were African American women, though the researchers were unsure as to why this particular trend emerged. 

    “We found that mothers who were older when they became pregnant were likely to have chronic hypertension,” said Dr. Ananth. “Since more women are electing to postpone their first pregnancies, and advanced maternal age is strongly associated with chronic high blood pressure, women should be aware of the risks associated with having high blood pressure during pregnancy.” 

    High blood pressure is something all consumers need to keep an eye on, but a new study shows that pregnant women can be especially susceptible to the condi...
    Read lessRead more

    Macleods recalls Losartan Potassium and Losartan Potassium/Hydrochlorothiazide tablets

    The products contain trace amounts of a potential human carcinogen

    Macleods Pharmaceuticals Limited is recalling Losartan Potassium tablets and Losartan Potassium/Hydrochlorothiazide combination tablets used to treat hypertension and hypertensive patients with Left Ventricular Hypertrophy.

    The products contain trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), a potential human carcinogen.

    The firm has not received any reports of adverse events to date.

    The following products, packaged in bottles, are being recalled:

    Losartan Potassium-

    Tablets 50 mg

    NDCManuf.Product DescriptionLotExpiration Date

    33342-

    045-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium.

    Tablets USP

    50mg 90ct

    BLl

    711A

    Nov-19

    33342-

    045-44

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium

    Tablets USP

    50mg 1000ct

    BLl

    710A

    Nov-19

    Losartan Potassium and Hydro-

    chlorothiazide Tablets 50 mg/ 12.5 mg

    NDCManuf.Product DescriptionLotExpiration Date

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide

    Tablets 50 mg/

    12.5 mg

    BLK7

    19A

    Sep-19

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide

    Tablets 50

    mg/ 12.5 mg

    BLK7

    20A

    Sep-19

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide

    Tablets 50

    mg/ 12.5 mg

    BLK7

    21A

    Sep-19

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium

    and Hydrochlor-othiazide Tablets 50 mg/ 12.5 mg

    BLK7

    22A

    Sep-19

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide

    Tablets 50

    mg/ 12.5 mg

    BLK7

    23A

    Sep-19

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide 

    Tablets 50 

    mg/ 12.5 mg

    BLK7

    24A

    Sep-19

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide 

    Tablets 50 

    mg/ 12.5 mg

    BLK7

    25A

    Oct-19

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide 

    Tablets 50 

    mg/ 12.5 mg

    BLK72

    6A

    Oct-19

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide 

    Tablets 50 

    mg/ 12.5 mg

    BLK8

    04A

    Jan-20

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide 

    Tablets 50 

    mg/ 12.5 mg

    BLK8

    06A

    Jan-20

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide 

    Tablets 50 

    mg/ 12.5 mg

    BLK8

    25A

    Oct-21

    33342-

    050-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium and Hydrochlor-

    othiazide 

    Tablets 50 

    mg/ 12.5 mg

    BLK8

    26A

    Oct-21

    Losartan Potassium and Hydrochlo.

    Tablets 100 mg/ 12.5 mg

    NDCManuf.Product DescriptionLotExpiration Date

    33342-

    051-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLL

    801A

    Dec-19

    33342-

    051-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLL

    802A

    Dec-19

    33342-

    051-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLL

    803A

    Dec-19

    Losartan Potassium and Hydrochlor.

    Tablets 100 mg/ 25 mg

    NDCManuf.Product DescriptionLotExpiration Date

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan

    Potassium

    and Hydrochlor-

    othiazide

    Tablets 100

    mg/ 25 mg

    BLM

    716A

    Jul-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    717A

    Jul-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    719A

    Aug-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    720A

    Aug-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    721A

    Sep-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    722A

    Sep-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    723A

    Oct-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    724A

    Oct-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    725A

    Oct-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    726A

    Nov-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    802A

    Dec-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    803A

    Dec-19

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    825A

    Sep-21

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    826A

    Sep-21

    33342-

    052-10

    Macleods Pharmac-

    euticals

    Limited

    Losartan 

    Potassium 

    and Hydrochlor-

    othiazide 

    Tablets 100

    mg/ 25 mg

    BLM

    827A

    Sep-21

    The products can be identified by checking the product name, manufacturer details and batch or lot number on the bottle.

    What to do

    Patients who are on the recalled medications should continue taking them and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment, as the risk of harm to the patient's health may be higher if the treatment is stopped immediately without any alternative treatment.

    Patients with medical questions regarding this recall or to report an adverse event may contact Macleods at (855) 926-3384 (8:00 am – 5:00 pm (EST).

    Macleods is arranging for return of all recalled products to Qualanex. Instructions for returning recalled products are given in the recall letter.

    Consumers with general questions regarding the return of the recalled product may contact Qualanex (888) 280-2046, 7:00 am to 4:00 pm (CST) Monday – Friday or by email at recall@qualanex .com.

    Macleods Pharmaceuticals Limited is recalling Losartan Potassium tablets and Losartan Potassium/Hydrochlorothiazide combination tablets used to treat hyper...
    Read lessRead more

    Teva expands recall of losartan potassium tablets

    The product contains trace amounts of a potential human carcinogen

    Teva Pharmaceuticals USA is expanding an earlier recall of losartan potassium tablets used for the treatment of hypertension, hypertensive patients with left ventricular hypertrophy, and nephropathy in Type 2 diabetic patients.

    The product contains trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), a potential human carcinogen.

    The expansion includes six (6) lots of bulk losartan potassium USP tablets: two lots of 50-mg strength and four lots of 100-mg strength.

    • Losartan potassium tablets, USP 50 mg, are green, film-coated, oval-shaped biconvex tablets with “LK 50” on one side and ">" on the other side.
    • Losartan potassium tablets, USP 100 mg, are dark green, film-coated, oval-shaped biconvex tablets with “LK100” on one side and ">" on the other side.

    The bulk lots were sold exclusively to Golden State Medical Supply, of Camarillo, Calif, which packaged these bulk products under its own label and distributed retail bottles of 30, 90 and 1000 tablets to their customers.

    The finished product lots included in this recall and listed below were sold by Teva in bulk containers.

    GSMS FG NDCsGSMS FG
    NDC Description
    GSMS FG Product LotsGSMS FG
    Expiration Dates
    60429-317-10LOSARTAN POTASSIUM 50 mg
    TABLETS, USP 1000 tablets/bottle
    GS01738701/2020
    60429-317-90LOSARTAN POTASSIUM 50 mg
    TABLETS 90 tablets/bottle
    GS01765101/2020
    60429-317-30LOSARTAN POTASSIUM 50 mg
    TABLETS 30 tablets/bottle
    GS01747901/2020
    60429-318-90LOSARTAN POTASSIUM 100 mg
    TABLETS 90 tablets/bottle
    GS01704201/2020
    60429-318-90LOSARTAN POTASSIUM 100 mg
    TABLETS 90 tablets/bottle
    GS01704301/2020
    60429-318-90LOSARTAN POTASSIUM 100 mg
    TABLETS, USP 90 tablets/bottle
    GS01704401/2020
    60429-318-90LOSARTAN POTASSIUM 100 mg
    TABLETS, USP 90 tablets/bottle
    GS01754101/2020

    The bulk tablet lots were repackaged into seven (7) finished product lots for further distribution by Golden State Medical Supply under its product label.

    What to do

    Patients taking Losartan Potassium tablets are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. The immediate risk of harm to a patient’s health is likely to be higher if the medicine is stopped abruptly without any alternative treatment.

    Patients with medical-related questions, who wish to report an adverse event, or quality issues about the recalled products may contact Teva Medical Information by at (888)838-2872, option 3, then, option 4, Monday-Friday, 9:00AM – 5:00PM (ET) with voicemail available 24 hours/day, 7 days/week, or by email at druginfo@tevapharm.com.

    Patients wishing to return product may contact Teva’s product recall processor (Inmar) to obtain instructions and a return kit for returning their medication.

    Contact Inmar at (877) 789-2065 from 9 am to 5 pm (ET) Monday – Friday) or by email Inmar at: tevarecalls@inmar.com.

    Inmar will provide the materials needed to return their medication and instructions for reimbursement.

    Teva Pharmaceuticals USA is expanding an earlier recall of losartan potassium tablets used for the treatment of hypertension, hypertensive patients with le...
    Read lessRead more

    Vivimed Life Sciences recalls of Losartan Potassium tablets

    The product contains trace amounts of a potential human carcinogen

    Vivimed Life Sciences is recalling 19 lots of Losartan Potassium 25-mg, 50-mg, and 100-mg tablets used for the treatment of hypertension, hypertensive patients with left ventricular hypertrophy, and nephropathy in Type 2 diabetic patients.

    The product contains trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), a potential human carcinogen.

    There are no reports of adverse events to date related to this recall.

    The following 19 lot numbers of Losartan Potassium tablets are being recalled:

    Product NameLot NumberPackExpiry DateDistributed by 
    Losartan Potassium Tablets USP, 25 mgCLO17006A90’sNov 2019HERITAGE  
    Losartan Potassium Tablets USP, 50 mgCLO17007A1000'sNov 2019HERITAGE   
    Losartan Potassium Tablets USP, 50 mgCLO17008A1000'sNov 2019HERITAGE   
    Losartan Potassium Tablets USP, 50 mgCLO17009A1000'sNov 2019HERITAGE   
    Losartan Potassium Tablets USP, 50 mgCLO17009B90'sNov 2019HERITAGE   
    Losartan Potassium Tablets USP, 50 mgCLO17010A90'sNov 2019HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO17012A90'sNov 2019HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO17013A90'sNov 2019HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO17014A1000'sDec 2019HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO17015A1000'sJan 2020HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO17016A1000'sJan 2020HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO17017A1000'sJan 2020HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO18001A1000'sJan 2020HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO18002A90'sJan 2020HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO18002B1000'sJan 2020HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO18020A90'sApr 2020HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO18021A90'sApr 2020HERITAGE   
    Losartan Potassium Tablets USP, 100 mgCLO18022A90'sApr 2020HERITAGE  
    Losartan Potassium Tablets USP, 50 mgCLO18023A90'sApr 2020HERITAGE  

    The recalled products were distributed nationwide to wholesalers, distributors, retail pharmacies, and mail order pharmacies.

    What to do

    Patients should contact their doctor for further guidance and potential change of treatment before they stop taking the product.

    Consumers with questions regarding the recall may call (877) 861-3811, Monday – Friday, 9am – 5pm (EST).

    Vivimed Life Sciences is recalling 19 lots of Losartan Potassium 25-mg, 50-mg, and 100-mg tablets used for the treatment of hypertension, hypertensive pati...
    Read lessRead more

    Teva Pharmaceuticals recalls Losartan Potassium tablets

    The product contains trace amounts of a potential human carcinogen

    Teva Pharmaceuticals USA is recalling 35 lots of bulk Losartan Potassium USP tablets used for the treatment of hypertension, hypertensive patients with left ventricular hypertrophy, and nephropathy in Type 2 diabetic patients.

    The product contains trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), a potential human carcinogen.

    The lots were sold exclusively to Golden State Medical Supply of Camarillo, Calif. Golden State Medical Supply packages this bulk product under its own label and distributes in retail bottles of 30, 90, and 1000 tablets.

    Teva has not received any reports to date of adverse events related to the lots being recalled.

    The finished product lots included in this voluntary recall and listed below were sold by Teva in bulk containers.

    GSMS FG

    NDCs

    GSMS FG
    NDC Description

    GSMS

    FG Product

    Lots

    GSMS FG

    Expiration

    Dates

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01404506/2019

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01430506/2019

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01405406/2019

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01404406/2019

    60429-

    316-10

    Losartan Potassium

    Tablets,

    USP, 25 mg,

    1,000 Count Bottle

    GS01481706/2019

    60429-

    316-90

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    90 Count Bottle

    GS01517206/2019

    60429-

    316-10

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    1,000 Count Bottle

    GS01520406/2019

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01633812/2019

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01634101/2020

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01634201/2020

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01634301/2020

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01634401/2020

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01634501/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01653501/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01652401/2020

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01653901/2020

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01696901/2020

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01697301/2020

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01733701/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg

    90 Count Bottle

    GS01738402/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01738501/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01753901/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01754001/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01754301/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01754201/2020

    60429-

    318-10

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    1,000 Count Bottle

    GS01852402/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01798402/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01798502/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01798602/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01826302/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01826402/2020

    60429-

    316-90

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    90 Count Bottle

    GS01763402/2020

    60429-

    316-90

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    90 Count Bottle

    GS01765302/2020

    60429-

    316-90

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    90 Count Bottle

    GS01798002/2020

    60429

    -316-30

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    30 Count Bottle

    GS01798102/2020

    60429-

    318-90

    Losartan Potassium,

    Tablets,

    USP, 100 mg,

    90 Count Bottle

    GS01826502/2020

    60429-

    316-90

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    90 Count Bottle

    GS01672602/2020

    60429-

    316-30

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    30 Count Bottle

    GS01695802/2020

    60429-

    316-90

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    90 Count Bottle

    GS01704502/2020

    60429-

    316-90

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    90 Count Bottle

    GS01727602/2020

    60429-

    316-30

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    30 Count Bottle

    GS01734102/2020

    60429-

    316-10

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    1,000 Count Bottle

    GS01831802/2020

    60429-

    316-10

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    1,000 Count Bottle

    GS01734202/2020

    60429-

    316-10

    Losartan Potassium,

    Tablets,

    USP, 25 mg,

    1,000 Count Bottle

    GS01780802/2020

    The bulk tablet lots were repackaged into 44 finished products lots for further distribution by Golden State Medical Supply under its product label.

    The recalled tablets are described as:

    • Losartan Potassium tablets, USP 25 mg, are light-green, film-coated, teardrop-shaped biconvex tablet with “LK 25” on one side and ">" on the other side.
    • Losartan Potassium tablets, USP 100 mg, are dark green, film-coated, oval-shaped biconvex tablets with “LK100” on one side and ">" on the other side.

    What to do

    Patients taking Losartan Potassium tablets are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. The immediate risk of harm to a patient’s health is likely to be higher if the medicine is stopped abruptly without any alternative treatment.

    Patients with medical-related questions, who wish to report an adverse event, or quality issues about the recalled products may contact Teva Medical Information by at (888)838-2872, option 3, then, option 4, Monday-Friday, 9:00AM – 5:00PM (ET) with voicemail available 24 hours/day, 7 days/week, or by email at druginfo@tevapharm.com.

    Patients wishing to return product may contact Teva’s product recall processor (Inmar) to obtain instructions and a return kit for returning their medication.

    Contact Inmar at (877) 789-2065 from 9 am to 5 pm (ET) Monday – Friday) or by email Inmar at: tevarecalls@inmar.com.

    Inmar will provide the materials needed to return their medication and instructions for reimbursement.

    Teva Pharmaceuticals USA is recalling 35 lots of bulk Losartan Potassium USP tablets used for the treatment of hypertension, hypertensive patients with lef...
    Read lessRead more

    Legacy Pharmaceutical expands Losartan Potassium tablet recall

    The product contains trace amounts of a potential human carcinogen

    Legacy Pharmaceutical Packaging is expanding its earlier recall of Losartan Potassium tablets, a prescription medication used to treat high blood pressure and congestive heart failure, to include one additional lot.

    The product contains trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), a potential human carcinogen.

    Legacy has not received any reports of adverse events to date.

    The following four repackaged lots numbers (3 initial repackaged lot and 1 expanded repackaged lot) , are being recalled:

    LEGACY NDC#Name and StrengthCountLegacy Lot #Expiry
    68645-494-54Losartan Potassium Tablets USP 50 mg3018019010/2020
    68645-494-54Losartan Potassium Tablets USP 50 mg3018019110/2020
    68645-494-54Losartan Potassium Tablets USP 50 mg3018159702/2021
    68645-494-54Losartan Potassium Tablets USP 50 mg3018159802/2021

    The product can be identified by checking the product name and repackaged lot number on the bottle containing these products.

    The recalled product was distributed by pharmacies nationwide.

    What to do

    Legacy is notifying its customers in writing and is arranging/assisting for return of all recalled products to Inmar Pharmaceutical Services.

    Instructions for returning recalled products are provided in the recall letter.

    Consumers with questions may contact Inmar at (877) 538-8443, Monday – Friday, 9am – 5pm EST.

    Legacy Pharmaceutical Packaging is expanding its earlier recall of Losartan Potassium tablets, a prescription medication used to treat high blood pressure...
    Read lessRead more

    Torrent expands recall of Losartan Potassium and Losartan Potassium/Hydrochlorothiazide tablets

    The products contain trace amounts of an unexpected impurity

    Torrent Pharmaceuticals Limited is expanding its earlier recall of Losartan Potassium tablets and Losartan Potassium/hydrochlorothiazide tablets.

    The products, used to treat high blood pressure, hypertensive patients with Left Ventricular Hypertrophy and nephropathy in Type 2 diabetic patients, contain trace amounts of an unexpected impurity, N-Methylnitrosobutyric acid that are above the acceptable daily intake levels released by the FDA.

    There are no reports to date of adverse events related to this recall.

    The expanded recall includes the following 36 lots of Losartan potassium tablets and 68 lots of Losartan Potassium/Hydrochlorothiazide tablets:

    NDCFinished Product Strength and Package CountBatch NumberExpiration Date
    13668-113-90Losartan Potassium Tablets, USP 25mg, 90 countBDK1C0037/31/2019
    13668-113-10Losartan Potassium Tablets, USP 25mg, 1000 countBDK1C0027/31/2019
    13668-113-10Losartan Potassium Tablets, USP 25mg, 1000 count4DU1D00412/31/2019
    13668-113-10Losartan Potassium Tablets, USP 25mg, 1000 count4DU1D00512/31/2019
    13668-113-10Losartan Potassium Tablets, USP 25mg, 1000 count4DU1D00612/31/2019
    13668-409-90Losartan Potassium Tablets, USP 50mg, 90 count4DU2D00512/31/2019
    13668-409-90Losartan Potassium Tablets, USP 50mg, 90 count4DU2D00612/31/2019
    13668-409-90Losartan Potassium Tablets, USP 50mg, 90 count4DU2D0263/31/2020
    13668-409-90Losartan Potassium Tablets, USP 50mg, 90 count4DU2D0273/31/2020
    13668-409-90Losartan Potassium Tablets, USP 50mg, 90 count4DU2D0293/31/2020
    13668-409-90Losartan Potassium Tablets, USP 50mg,90 count4DU2E00712/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0408/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0418/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0428/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0172/29/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0253/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0283/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0458/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0468/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0478/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2D0488/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2E0422/28/2021
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 count4DU2E0442/28/2021
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 countBDK2E00112/31/2020
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 countBDK2E0128/31/2021
    13668-409-10Losartan Potassium Tablets, USP 50mg, 1000 countBDK2E0138/31/2021
    13668-115-90Losartan Potassium Tablets, USP 100mg, 90 count4DU3E0161/31/2021
    13668-115-10Losartan Potassium Tablets, USP 100mg, 1000 count4DU3E0171/31/2021
    13668-115-10Losartan Potassium Tablets, USP 100mg, 1000 count4DU3E0192/28/2021
    13668-115-10Losartan Potassium Tablets, USP 100mg, 1000 count4DU3C0127/31/2019
    13668-115-10Losartan Potassium Tablets, USP 100mg, 1000 count4DU3C0158/31/2019
    13668-115-10Losartan Potassium Tablets, USP 100mg, 1000 count4DU3C0168/31/2019
    13668-115-10Losartan Potassium Tablets, USP 100mg, 1000 count4DU3C0178/31/2019
    13668-115-10Losartan Potassium Tablets, USP 100mg, 1000 count4DU3C0319/30/2019
    13668-115-10Losartan Potassium Tablets, USP 100mg, 1000 count4DU3D0071/31/2020
    13668-115-10Losartan Potassium Tablets, USP 100mg, 1000 count4DU3D0081/31/2020
    13668-116-30Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 30 countBP02D00512/31/2019
    13668-116-30Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 30 countBP02C05110/31/2019
    13668-116-30Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 30 countBEF7D04711/30/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBP02D00612/31/2019
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBP02D00712/31/2019
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBP02D0121/31/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBEF7D0033/31/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBP02C05010/31/2019
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBEF7D0268/31/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBEF7D0278/31/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBEF7D0288/31/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBEF7D04511/30/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBEF7D04611/30/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 countBEF7E0051/31/2021
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBEF7D0053/31/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBEF7D0298/31/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBEF7D0308/31/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBEF7D04811/30/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBEF7E00112/31/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBEF7E00212/31/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBEF7E00312/31/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBEF7E00412/31/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBP02C05110/31/2019
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 1000 countBP02C05210/31/2019
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/12.5mg, 90 countBEF8D06011/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/12.5mg, 90 countBEF8D06111/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/12.5mg, 90 countBEF8D06211/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/12.5mg, 90 countBEF8D06311/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/12.5mg, 90 countBX35D0241/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/12.5mg, 90 countBEF8D06411/30/2020
    13668-117-10Losartan Potassium /Hydrochlorothiazide Tablets, USP 100mg/12.5mg, 1000 countBEF8D05911/30/2020
    13668-117-10Losartan Potassium /Hydrochlorothiazide Tablets, USP 100mg/12.5mg, 1000 countBEF8E0041/31/2021
    13668-117-10Losartan Potassium /Hydrochlorothiazide Tablets, USP 100mg/12.5mg, 1000 countBEF8E0051/31/2021
    13668-118-30Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 30 countBEF6D0548/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D10011/30/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D10111/30/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D10211/30/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6E00112/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6E00212/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6E00312/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6E00412/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6E00812/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6E00912/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6E01012/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6E01112/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6E01212/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBP04D01212/31/2019
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBP04D01312/31/2019
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBP04C09210/31/2019
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D0123/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D0133/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D0609/30/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D0619/30/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D0639/30/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D07610/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D07710/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D07810/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 countBEF6D07910/31/2020
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBP04C09410/31/2019
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBEF6D09611/30/2020
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBEF6D09711/30/2020
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBEF6D09811/30/2020
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBEF6D09911/30/2020
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBEF6E00512/31/2020
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBEF6E00612/31/2020
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBP04D0162/29/2020
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBP04D0172/29/2020
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 1000 countBP04D0182/29/2020

    What to do

    Patients who are taking the recalled products should continue taking their medication, as the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment.

    Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.

    Torrent is notifying its customers by phone and in writing, and arranging for return of all recalled products to Qualanex. Instructions for returning recalled products are given in the recall letter.

    Consumers with medical questions regarding this recall or to report an adverse event may contact Torrent Pharmaceuticals Limited at (800) 912-9561 from 8:00 am – 5:00 pm (ET) with voicemail available 24/7, or by email at Medinfo.Torrent@apcerls.com

    Consumers with general questions regarding the return of the recalled product may contact Qualanex at (888) 280-2040 from 8 am - 9:00 pm ET).

    Torrent Pharmaceuticals Limited is expanding its earlier recall of Losartan Potassium tablets and Losartan Potassium/hydrochlorothiazide tablets.The pr...
    Read lessRead more

    Legacy Pharmaceutical recalls Losartan Potassium tablets

    The product contains trace amounts of a potential human carcinogen

    Legacy Pharmaceutical Packaging is recalling 40 repackaged lots of Losartan tablets, a prescription medication used to treat high blood pressure and congestive heart failure.

    The product contains trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), a potential human carcinogen.

    Legacy has not received any reports of adverse events to date.

    The following product, packaged in 30-count bottles, is being recalled:

    LEGACY NDC#Name and StrengthCountLegacy Lot #Expiry
    68645-577-54Losartan Potassium Tablets USP 25 mg3018095210/2019
    68645-577-54Losartan Potassium Tablets USP 25 mg3018095312/2019
    68645-577-54Losartan Potassium Tablets USP 25 mg3018108609/2019
    68645-577-54Losartan Potassium Tablets USP 25 mg3018157201/2020
    68645-578-54Losartan Potassium Tablets USP 50 mg3018092109/2019
    68645-578-54Losartan Potassium Tablets USP 50 mg3018092210/2019
    68645-578-54Losartan Potassium Tablets USP 50 mg3018092311/2019
    68645-578-54Losartan Potassium Tablets USP 50 mg3018092411/2019
    68645-578-54Losartan Potassium Tablets USP 50 mg3018111811/2019
    68645-578-54Losartan Potassium Tablets USP 50 mg3018111910/2019
    68645-578-54Losartan Potassium Tablets USP 50 mg3018140711/2019
    68645-578-54Losartan Potassium Tablets USP 50 mg3018140812/2019
    68645-578-54Losartan Potassium Tablets USP 50 mg3018157302/2020
    68645-578-54Losartan Potassium Tablets USP 50 mg3018172502/2020
    68645-578-54Losartan Potassium Tablets USP 50 mg3018172602/2020
    68645-578-54Losartan Potassium Tablets USP 50 mg3018194803/2020
    68645-578-54Losartan Potassium Tablets USP 50 mg3018196002/2020
    68645-578-54Losartan Potassium Tablets USP 50 mg3018238503/2020
    68645-578-54Losartan Potassium Tablets USP 50 mg3018238603/2020
    68645-578-54Losartan Potassium Tablets USP 50 mg3018238703/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018088611/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018088712/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018088812/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018090512/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018112309/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018112410/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018112508/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018135111/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018135212/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018155111/2019
    68645-579-54Losartan Potassium Tablets USP 100 mg3018162806/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018162906/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018172706/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018172806/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018189003/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018189106/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018189706/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018211403/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018211906/2020
    68645-579-54Losartan Potassium Tablets USP 100 mg3018212006/2020

    The recalled product, which can be identified by checking the product name and repackaged lot number on the bottle, was distributed by pharmacies nationwide.

    What to do

    Patients who have the recalled product should return it to the dispensing pharmacy.

    Consumers with questions regarding this recall should contact their dispensing pharmacy during normal business hours or their physician or healthcare provider if they have had any problems related to taking or using the product.

    Legacy Pharmaceutical Packaging is recalling 40 repackaged lots of Losartan tablets, a prescription medication used to treat high blood pressure and conges...
    Read lessRead more

    American Health Packaging recalls Valsartan tablets

    The product contains trace amounts of NDEA impurity

    American Health Packaging is recalling one lot of Valsartan tablets, which are used to control high blood pressure and for the treatment of heart failure.

    Trace amounts of an unexpected impurity, N-nitrosodiethylamine (NDEA) -- a probable human carcinogen – have been found in the product.

    There are no reports of injury or adverse events to date.

    The following product, which was distributed nationwide, is being recalled:

    Product DescriptionAHP Lot No.Expiration Date

    Valsartan Tablets USP 160 mg

    100 count Unit Dose Blisters
    Carton NDC#: 60687-139-01
    (Individual Dose NDC: 60687-139-11)

    1797913/31/2020

    What to do

    Patients should continue taking their medication, as the risk of harm to their health may be higher if the treatment is stopped immediately without any alternative treatment. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.

    Consumers who have the recalled product should call (877) 475-5864 to receive a return packet.

    American Health Packaging is recalling one lot of Valsartan tablets, which are used to control high blood pressure and for the treatment of heart failure....
    Read lessRead more

    AurobindoPharma USA recalls Amlodipine Valsartan and Valsartan tablets

    The product contains trace amounts of NDEA impurity.

    AurobindoPharma USA and Acetris Health are expanding an earlier recall of Valsartan and Amlodipine and Valsartan tablets, which are used to control high blood pressure and for the treatment of heart failure.

    Trace amounts of an unexpected impurity, N-nitrosodiethylamine (NDEA) -- a probable human carcinogen – have been found in the product.

    The following products, packaged in bottles, are being recalled:

    NDCTypeCountLot numberExpiry

    ACETRIS LOTS

    52343-

    122-

    30

    Valsartan

    Tablets

    USP 40mg

    30

    470170

    038A

    19-Oct

    52343-

    122-

    30

    Valsartan

    Tablets

    USP 40mg

    30

    470180

    010A

    20-Feb

    52343-

    122-

    30

    Valsartan

    Tablets

    USP 40mg

    30

    470180

    012A

    20-Mar

    52343-

    123-

    90

    Valsartan

    Tablets

    USP 80mg

    90

    471170

    019A

    19-Oct

    52343-

    123-

    90

    Valsartan

    Tablets

    USP 80mg

    90

    471180

    006A

    20-Mar

    52343-

    123-

    90

    Valsartan

    Tablets

    USP 80mg

    90

    471180

    007A

    20-Mar

    52343-

    123-

    90

    Valsartan

    Tablets

    USP 80mg

    90

    471180

    016A

    20-May

    52343-

    124-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    005B

    20-Feb

    52343-

    124-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    011A

    20-Apr

    52343-

    124-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    012A

    20-Apr

    52343-

    125-

    90

    Valsartan

    Tablets

    USP 320mg

    90

    473180

    007A

    20-Mar

    52343-

    125-

    90

    Valsartan

    Tablets

    USP 320mg

    90

    473180

    008A

    20-Mar

    52343-

    125-

    90

    Valsartan

    Tablets

    USP 320mg

    90

    473180

    011A

    20-Apr

    52343-

    125-

    90

    Valsartan

    Tablets

    USP 320mg

    90

    473180

    020B1

    20-Jul

    52343-

    125-

    90

    Valsartan

    Tablets

    USP 320mg

    90

    473170

    019B

    19-Oct

    AUROBINDO LOTS

    65862-

    570-

    30

    Valsartan

    Tablets

    USP 40mg

    30

    470180

    008A

    20-Feb

    65862-

    570-

    30

    Valsartan

    Tablets

    USP 40mg

    30

    470180

    014A

    20-Mar

    65862-

    570-

    30

    Valsartan

    Tablets

    USP 40mg

    30

    47018

    0016A

    20-Mar

    65862-

    571-

    90

    Valsartan

    Tablets

    USP 80mg

    90

    471170

    015A

    19-Sep

    65862-

    571-

    90

    Valsartan

    Tablets

    USP 80mg

    90

    471180

    004A

    20-Feb

    65862-

    571-

    90

    Valsartan

    Tablets

    USP 80mg

    90

    471180

    005A

    20-Feb

    65862-

    572-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    001A

    20-Jan

    65862-

    572-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    002A

    20-Jan

    65862-

    572-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    003A

    20-Jan

    65862-

    572-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    004A

    20-Jan

    65862-

    572-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    007A

    20-Mar

    65862-

    572-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    008A

    20-Mar

    65862-

    572-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    009A

    20-Mar

    65862-

    572-

    90

    Valsartan

    Tablets

    USP 160mg

    90

    472180

    010A

    20-Mar

    65862-

    572-

    90

    Valsartan

    Tablets

    USP

    160mg

    90

    47218

    0013A

    20-Apr

    65862-

    572-

    90

    Valsartan

    Tablets

    USP

    160mg

    90

    472180

    014A

    20-Apr

    65862-

    573-

    90

    Valsartan

    Tablets

    USP

    320mg

    90

    4731800

    04A

    20-Feb

    65862-

    573-

    90

    Valsartan

    Tablets

    USP

    320mg

    90

    473180

    005A

    20-Feb

    65862-

    573-

    90

    Valsartan

    Tablets

    USP

    320mg

    90

    473180

    006A

    20-Mar

    65862-

    573-

    90

    Valsartan

    Tablets

    USP

    320mg

    90

    47318

    0017A

    20-May

    65862-

    739-

    30

    Amlodipine

    and

    Valsartan

    Tablets

    USP

    10mg

    /160mg

    30

    VFSA17

    007-A

    19-Oct

    65862-

    570-

    30

    Valsartan

    Tablets

    USP

    40mg

    30

    470180

    032A

    20-May

    65862-

    573-

    90

    Valsartan

    Tablets

    USP

    320mg

    90

    473170

    019A

    19-Oct

    65862-

    573-

    90

    Valsartan

    Tablets

    USP

    320mg

    90

    473180

    016A

    The recalled products were distributed nationwide.

    What to do

    Patients should continue taking their medication, as the risk of harm to their health may be higher if the treatment is stopped immediately without any alternative treatment. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.

    AurobindoPharma is notifying its customers by phone and in writing and arranging for return of all recalled products. Instructions for returning recalled products are given in the recall letter.

    Consumers with medical questions regarding this recall may contact AurobindoPharma at (866) 850- 2876, Option 2 or by email at pvg@aurobindousa.com.

    AurobindoPharma USA and Acetris Health are expanding an earlier recall of Valsartan and Amlodipine and Valsartan tablets, which are used to control high bl...
    Read lessRead more

    Drinking moderately could contribute to high blood pressure

    Cutting back can help consumers avoid hypertension, researchers say

    Recent studies have noted the health risks associated with consuming alcohol -- even in moderation. Now, consumers can add blood pressure to the list of potential issues.

    According to a new study, consuming as few as seven to 13 drinks per week can lead to high blood pressure.

    “I think this will be a turning point for clinical practice, as well as for future research, education, and public health policy regarding alcohol consumption,” said researcher Dr. Amer Aladin. “It’s the first study showing that both heavy and moderate alcohol consumption can increase hypertension.”

    Moderation is still a risk

    To gauge the relationship between alcohol consumption and blood pressure, the researchers utilized six years worth of data from the Center for Disease Control and Prevention’s (CDC) National Health and Nutrition Examination Study (NHANES).

    The researchers included over 17,000 participants in the study, dividing them into three groups based on how much they drank: one group for those who never drank, another group for those who drank moderately (seven to 13 drinks per week), and a third group for heavy drinkers (14 or more drinks per week).

    The researchers evaluated blood pressure using the American College of Cardiology (ACC) and American Heart Association’s (AHA) 2017 guidelines, which lowers the barometer for what was traditionally considered hypertensive to 130/80 mm Hg, and places a normal blood pressure at 120/80 mm Hg.

    The biggest takeaway from the study was that the more the participants drank on a weekly basis, the greater their likelihood of developing stage 1 or stage 2 hypertension. Heavy drinkers were the most affected, as the researchers found that these participants had a nearly 70 percent chance of developing stage 1 hypertension. They were also nearly 2.5 times as likely to develop stage 2 hypertension.

    Moderate drinkers fared only slightly better, showing an over 50 percent risk of stage 1 hypertension and double the risk of developing stage 2 hypertension. The researchers hope these findings are beneficial for consumers moving forward, and that they pay close to attention to both their blood pressure readings and alcohol intake in the future.

    “This study is not only large, but diverse in terms of race and gender,” Dr. Aladin said. “The results are very informative for future research and practice. If you are drinking a moderate or large amount of alcohol, ask your provider to check your blood pressure at each visit and help you cut down your drinking and eventually quit.”

    Maintaining healthy blood pressure

    Keeping blood pressure within a healthy range can be difficult for many consumers, but researchers have figured out several ways to make the process a bit easier.

    Researchers recently found that both blueberries and napping can be effective for lowering blood pressure. Laws that regulate smoking indoors have also been linked to lowering blood pressure.

    Recent studies have noted the health risks associated with consuming alcohol -- even in moderation. Now, consumers can add blood pressure to the list of po...
    Read lessRead more

    Torrent Pharmaceuticals recalls Losartan Potassium and Losartan Potassium /Hydrochlorothiazide tablets

    The products contain trace amounts of an unexpected impurity

    Torrent Pharmaceuticals Limited is recalling 60 lots of Losartan potassium tablets and 54 lots of Losartan potassium/ hydrochlorothiazide tablets

    The products, used to treat high blood pressure, contain trace amounts of an unexpected impurity, N-Methylnitrosobutyric acid (NMBA), that are above the acceptable daily intake levels released by the FDA.

    There are no reports to date of adverse events related to this recall.

    The following products are being recalled:

    NDCFinished Product Strength
    and Package Count
    Batch NumberExpiration Date
    13668-113-90Losartan Potassium Tablets,
    USP 25mg,
    90 count
    4DU1E0051/31/2021
    13668-113-90Losartan Potassium Tablets,
    USP 25mg,
    90 count
    4DU1E0061/31/2021
    13668-113-90Losartan Potassium Tablets,
    USP 25mg,
    90 count
    4DU1E0081/31/2021
    13668-113-10Losartan Potassium Tablets,
    USP 25mg,
    1000 count
    4DU1E0071/31/2021
    13668-409-30Losartan Potassium Tablets,
    USP 50mg,
    30 count
    4DU2D07710/31/2020
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4DU2D08710/31/2020
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4DU2E0231/31/2021
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4DU2E0241/31/2021
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4DU2E0261/31/2021
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4DU2E0271/31/2021
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4DU2E0281/31/2021
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4DU2E0291/31/2021
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4DU2E0201/31/2021
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4O50E0078/31/2021
    13668-409-90Losartan Potassium Tablets,
    USP 50mg,
    90 count
    4O50E0088/31/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D0679/30/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D0699/30/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D0639/30/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D0649/30/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D0659/30/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D0669/30/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D08410/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D08510/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D08310/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D08210/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D07210/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D07710/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D07810/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D07910/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D08110/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D08010/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D07010/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D07310/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D07410/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D07510/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D08610/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D08810/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2D08910/31/2020
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0191/31/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0211/31/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0221/31/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0251/31/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0322/28/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0332/28/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0342/28/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0352/28/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0362/28/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0372/28/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0382/28/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0392/28/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E0412/28/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E1036/30/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E1016/30/2021
    13668-409-10Losartan Potassium Tablets,
    USP 50mg,
    1000 count
    4DU2E1026/30/2021
    13668-115-90Losartan Potassium Tablets,
    USP 100mg,
    90 count
    4DU3E0141/31/2021
    13668-115-90Losartan Potassium Tablets,
    USP 100mg,
    90 count
    4DU3E0151/31/2021
    13668-115-90Losartan Potassium Tablets,
    USP 100mg,
    90 count
    4DU3E0657/31/2021
    13668-115-10Losartan Potassium Tablets,
    USP 100mg,
    1000 count
    4DU3D01811/30/2020
    13668-115-10Losartan Potassium Tablets,
    USP 100mg,
    1000 count
    4DU3E0626/30/2021
    13668-115-10Losartan Potassium Tablets,
    USP 100mg,
    1000 count
    4DU3E0636/30/2021
    13668-116-30Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    30 count
    BEF7D0176/30/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    90 count
    BEF7D0104/30/2020
    13668-116-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    90 count
    BEF7D0114/30/2020
    13668-116-90Losartan Potassium /Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    90 count
    BEF7D0186/30/2020
    13668-116-90Losartan Potassium / Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    90 count
    BEF7D0094/30/2020
    13668-116-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    90 count
    4P02E0021/31/2021
    13668-116-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    90 count
    4P02E0031/31/2021
    13668-116-90Losartan Potassium / Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    90 count
    4P02E0041/31/2021
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    1000 count
    BEF7D0084/30/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    1000 count
    BEF7D0228/31/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    1000 count
    BEF7D0124/30/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    1000 count
    BEF7D0134/30/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    1000 count
    BEF7D04911/30/2020
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    1000 count
    4P02E0051/31/2021
    13668-116-10Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 50mg/12.5mg,
    1000 count
    4P02E0061/31/2021
    13668-117-30Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    30 count
    BEF8D05811/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0234/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0244/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0254/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0093/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0103/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0113/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0123/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0133/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D05410/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D05510/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D05610/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D05711/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0073/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0083/31/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0204/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0214/30/2020
    13668-117-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/12.5mg,
    90 count
    BEF8D0224/30/2020
    13668-118-30Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    30 count
    BEF6D0384/30/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D0304/30/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D0314/30/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D0477/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90count
    BEF6D0487/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D0497/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D0507/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D0517/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D08210/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D08310/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D08410/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D08510/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D08610/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    BEF6D08710/31/2020
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    4P04E0031/31/2021
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    4P04E0041/31/2021
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    4P04E0051/31/2021
    13668-118-90Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    90 count
    4P04E0061/31/2021
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    1000 count
    4P04E0071/31/2021
    13668-118-10Losartan Potassium/Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    1000 count
    4P04E0081/31/2021
    13668-118-10Losartan Potassium/ Hydrochlorothiazide Tablets,
    USP 100mg/25mg,
    1000 count
    4P04E0091/31/2021

    The recalled products were distributed nationwide to Torrent’s wholesale distributor, repackager and retail customers

    What to do

    Patients who are taking the medications should continue to do so, as the risk of harm to their health may be higher if the treatment is stopped immediately without any alternative treatment.

    Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.

    Torrent is arranging for return of all recalled products to Qualanex. Instructions for returning recalled products are given in a letter being sent to all customers.

    Consumers with medical questions regarding this recall may contact Torrent Pharmaceuticals at (800) 912-9561 from 8:00 am – 5:00 pm (ET) or by email at Medinfo.Torrent@apcerls.com

    Torrent Pharmaceuticals Limited is recalling 60 lots of Losartan potassium tablets and 54 lots of Losartan potassium/ hydrochlorothiazide tabletsThe pr...
    Read lessRead more